CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

San Clemente Villas By The Sea

San Clemente Villas By The Sea is a San Clemente, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cannus Partners

Cannus Partners Inc. operates as a specialty pharmaceutical company. The Company cultivates, processes, and distributes cannabis. Cannus Partners serves customers in the United States and Canada.

UHealth Solutions

UHealth Solutions is a Worcester, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

JJ WIld

JJ WIld is a Canton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Capital Senior Living

Capital Senior Living Corporation is one of the nation`s largest operators of residential communities for senior adults. With a goal of offering affordable housing and an enriched lifestyle to thousands of seniors, our dedicated team of professionals succeeds in providing quality care in each of our unique communities.